Go Pro

Bowhead Specialty (BOW) Competitors

Bowhead Specialty logo
$33.68 +3.09 (+10.10%)
Closing price 03:59 PM Eastern
Extended Trading
$33.74 +0.06 (+0.19%)
As of 04:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BOW vs. HGTY, FG, BWIN, ALHC, and PLMR

Should you buy Bowhead Specialty stock or one of its competitors? MarketBeat compares Bowhead Specialty with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Bowhead Specialty include Hagerty (HGTY), F&G Annuities & Life (FG), Baldwin Insurance Group (BWIN), Alignment Healthcare (ALHC), and Palomar (PLMR).

How does Bowhead Specialty compare to Hagerty?

Hagerty (NYSE:HGTY) and Bowhead Specialty (NYSE:BOW) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, institutional ownership, media sentiment and profitability.

Bowhead Specialty has a net margin of 9.99% compared to Hagerty's net margin of 5.11%. Bowhead Specialty's return on equity of 13.80% beat Hagerty's return on equity.

Company Net Margins Return on Equity Return on Assets
Hagerty5.11% 11.94% 3.61%
Bowhead Specialty 9.99%13.80%2.71%

Bowhead Specialty has lower revenue, but higher earnings than Hagerty. Bowhead Specialty is trading at a lower price-to-earnings ratio than Hagerty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hagerty$1.44B2.75$49.02M$0.2057.63
Bowhead Specialty$584.46M1.89$53.79M$1.7319.47

20.5% of Hagerty shares are held by institutional investors. 3.7% of Hagerty shares are held by insiders. Comparatively, 4.2% of Bowhead Specialty shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Hagerty has a beta of 0.79, indicating that its stock price is 21% less volatile than the broader market. Comparatively, Bowhead Specialty has a beta of -0.1, indicating that its stock price is 110% less volatile than the broader market.

In the previous week, Bowhead Specialty had 11 more articles in the media than Hagerty. MarketBeat recorded 14 mentions for Bowhead Specialty and 3 mentions for Hagerty. Hagerty's average media sentiment score of 0.29 beat Bowhead Specialty's score of 0.10 indicating that Hagerty is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hagerty
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Bowhead Specialty
4 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Hagerty presently has a consensus price target of $13.67, suggesting a potential upside of 18.58%. Bowhead Specialty has a consensus price target of $33.43, suggesting a potential downside of 0.75%. Given Hagerty's higher possible upside, analysts plainly believe Hagerty is more favorable than Bowhead Specialty.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hagerty
0 Sell rating(s)
5 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.44
Bowhead Specialty
0 Sell rating(s)
5 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.44

Summary

Hagerty beats Bowhead Specialty on 8 of the 14 factors compared between the two stocks.

How does Bowhead Specialty compare to F&G Annuities & Life?

Bowhead Specialty (NYSE:BOW) and F&G Annuities & Life (NYSE:FG) are both finance companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, media sentiment, valuation and institutional ownership.

95.9% of F&G Annuities & Life shares are owned by institutional investors. 4.2% of Bowhead Specialty shares are owned by insiders. Comparatively, 2.5% of F&G Annuities & Life shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Bowhead Specialty had 12 more articles in the media than F&G Annuities & Life. MarketBeat recorded 14 mentions for Bowhead Specialty and 2 mentions for F&G Annuities & Life. F&G Annuities & Life's average media sentiment score of 0.89 beat Bowhead Specialty's score of 0.10 indicating that F&G Annuities & Life is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bowhead Specialty
4 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
F&G Annuities & Life
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

F&G Annuities & Life has higher revenue and earnings than Bowhead Specialty. F&G Annuities & Life is trading at a lower price-to-earnings ratio than Bowhead Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bowhead Specialty$584.46M1.89$53.79M$1.7319.47
F&G Annuities & Life$5.66B0.68$265M$3.817.60

Bowhead Specialty presently has a consensus target price of $33.43, suggesting a potential downside of 0.75%. F&G Annuities & Life has a consensus target price of $30.00, suggesting a potential upside of 3.62%. Given F&G Annuities & Life's higher probable upside, analysts clearly believe F&G Annuities & Life is more favorable than Bowhead Specialty.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bowhead Specialty
0 Sell rating(s)
5 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.44
F&G Annuities & Life
0 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Bowhead Specialty has a net margin of 9.99% compared to F&G Annuities & Life's net margin of 8.89%. Bowhead Specialty's return on equity of 13.80% beat F&G Annuities & Life's return on equity.

Company Net Margins Return on Equity Return on Assets
Bowhead Specialty9.99% 13.80% 2.71%
F&G Annuities & Life 8.89%10.73%0.53%

Bowhead Specialty has a beta of -0.1, suggesting that its stock price is 110% less volatile than the broader market. Comparatively, F&G Annuities & Life has a beta of 1.23, suggesting that its stock price is 23% more volatile than the broader market.

Summary

Bowhead Specialty beats F&G Annuities & Life on 9 of the 16 factors compared between the two stocks.

How does Bowhead Specialty compare to Baldwin Insurance Group?

Baldwin Insurance Group (NASDAQ:BWIN) and Bowhead Specialty (NYSE:BOW) are both finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk, dividends and media sentiment.

In the previous week, Baldwin Insurance Group had 6 more articles in the media than Bowhead Specialty. MarketBeat recorded 20 mentions for Baldwin Insurance Group and 14 mentions for Bowhead Specialty. Baldwin Insurance Group's average media sentiment score of 0.70 beat Bowhead Specialty's score of 0.10 indicating that Baldwin Insurance Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Baldwin Insurance Group
4 Very Positive mention(s)
4 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Bowhead Specialty
4 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Bowhead Specialty has lower revenue, but higher earnings than Baldwin Insurance Group. Baldwin Insurance Group is trading at a lower price-to-earnings ratio than Bowhead Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baldwin Insurance Group$1.50B2.79-$33.81M-$1.04N/A
Bowhead Specialty$584.46M1.89$53.79M$1.7319.47

Baldwin Insurance Group currently has a consensus target price of $30.33, indicating a potential upside of 2.89%. Bowhead Specialty has a consensus target price of $33.43, indicating a potential downside of 0.75%. Given Baldwin Insurance Group's stronger consensus rating and higher probable upside, equities analysts plainly believe Baldwin Insurance Group is more favorable than Bowhead Specialty.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Baldwin Insurance Group
1 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.55
Bowhead Specialty
0 Sell rating(s)
5 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.44

77.5% of Baldwin Insurance Group shares are held by institutional investors. 15.8% of Baldwin Insurance Group shares are held by insiders. Comparatively, 4.2% of Bowhead Specialty shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Bowhead Specialty has a net margin of 9.99% compared to Baldwin Insurance Group's net margin of -4.67%. Bowhead Specialty's return on equity of 13.80% beat Baldwin Insurance Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Baldwin Insurance Group-4.67% 12.67% 3.32%
Bowhead Specialty 9.99%13.80%2.71%

Baldwin Insurance Group has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market. Comparatively, Bowhead Specialty has a beta of -0.1, meaning that its stock price is 110% less volatile than the broader market.

Summary

Baldwin Insurance Group beats Bowhead Specialty on 12 of the 17 factors compared between the two stocks.

How does Bowhead Specialty compare to Alignment Healthcare?

Bowhead Specialty (NYSE:BOW) and Alignment Healthcare (NASDAQ:ALHC) are related companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, media sentiment, profitability, valuation, dividends, analyst recommendations and risk.

In the previous week, Alignment Healthcare had 33 more articles in the media than Bowhead Specialty. MarketBeat recorded 47 mentions for Alignment Healthcare and 14 mentions for Bowhead Specialty. Alignment Healthcare's average media sentiment score of 0.38 beat Bowhead Specialty's score of 0.10 indicating that Alignment Healthcare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bowhead Specialty
4 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Alignment Healthcare
8 Very Positive mention(s)
7 Positive mention(s)
22 Neutral mention(s)
4 Negative mention(s)
2 Very Negative mention(s)
Neutral

86.2% of Alignment Healthcare shares are owned by institutional investors. 4.2% of Bowhead Specialty shares are owned by insiders. Comparatively, 5.2% of Alignment Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Bowhead Specialty has a beta of -0.1, meaning that its share price is 110% less volatile than the broader market. Comparatively, Alignment Healthcare has a beta of 1.05, meaning that its share price is 5% more volatile than the broader market.

Bowhead Specialty presently has a consensus target price of $33.43, suggesting a potential downside of 0.75%. Alignment Healthcare has a consensus target price of $24.00, suggesting a potential upside of 64.84%. Given Alignment Healthcare's stronger consensus rating and higher possible upside, analysts plainly believe Alignment Healthcare is more favorable than Bowhead Specialty.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bowhead Specialty
0 Sell rating(s)
5 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.44
Alignment Healthcare
0 Sell rating(s)
4 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.64

Bowhead Specialty has a net margin of 9.99% compared to Alignment Healthcare's net margin of 0.89%. Alignment Healthcare's return on equity of 20.02% beat Bowhead Specialty's return on equity.

Company Net Margins Return on Equity Return on Assets
Bowhead Specialty9.99% 13.80% 2.71%
Alignment Healthcare 0.89%20.02%3.46%

Bowhead Specialty has higher earnings, but lower revenue than Alignment Healthcare. Bowhead Specialty is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bowhead Specialty$584.46M1.89$53.79M$1.7319.47
Alignment Healthcare$4.58B0.66-$720K$0.1976.63

Summary

Alignment Healthcare beats Bowhead Specialty on 12 of the 16 factors compared between the two stocks.

How does Bowhead Specialty compare to Palomar?

Palomar (NASDAQ:PLMR) and Bowhead Specialty (NYSE:BOW) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, media sentiment, earnings, analyst recommendations, profitability and risk.

Palomar presently has a consensus target price of $162.50, suggesting a potential upside of 19.04%. Bowhead Specialty has a consensus target price of $33.43, suggesting a potential downside of 0.75%. Given Palomar's stronger consensus rating and higher possible upside, equities research analysts plainly believe Palomar is more favorable than Bowhead Specialty.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Palomar
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67
Bowhead Specialty
0 Sell rating(s)
5 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.44

Palomar has a beta of 0.41, suggesting that its share price is 59% less volatile than the broader market. Comparatively, Bowhead Specialty has a beta of -0.1, suggesting that its share price is 110% less volatile than the broader market.

Palomar has a net margin of 20.11% compared to Bowhead Specialty's net margin of 9.99%. Palomar's return on equity of 22.62% beat Bowhead Specialty's return on equity.

Company Net Margins Return on Equity Return on Assets
Palomar20.11% 22.62% 6.60%
Bowhead Specialty 9.99%13.80%2.71%

Palomar has higher revenue and earnings than Bowhead Specialty. Palomar is trading at a lower price-to-earnings ratio than Bowhead Specialty, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Palomar$980.27M3.69$197.07M$7.1819.01
Bowhead Specialty$584.46M1.89$53.79M$1.7319.47

In the previous week, Palomar had 2 more articles in the media than Bowhead Specialty. MarketBeat recorded 16 mentions for Palomar and 14 mentions for Bowhead Specialty. Palomar's average media sentiment score of 0.67 beat Bowhead Specialty's score of 0.10 indicating that Palomar is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Palomar
11 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
Bowhead Specialty
4 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

90.3% of Palomar shares are held by institutional investors. 3.7% of Palomar shares are held by company insiders. Comparatively, 4.2% of Bowhead Specialty shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Palomar beats Bowhead Specialty on 13 of the 15 factors compared between the two stocks.

Get Bowhead Specialty News Delivered to You Automatically

Sign up to receive the latest news and ratings for BOW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BOW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BOW vs. The Competition

MetricBowhead SpecialtyInsurance IndustryFinance SectorNYSE Exchange
Market Cap$1.11B$19.59B$13.97B$23.85B
Dividend YieldN/A3.27%5.96%4.22%
P/E Ratio19.4715.5628.7831.51
Price / Sales1.8928.92465.03166.54
Price / Cash17.8712.4729.9518.72
Price / Book2.469.873.714.83
Net Income$53.79M$1.81B$1.31B$1.07B
7 Day Performance7.85%0.74%0.81%0.84%
1 Month Performance6.92%1.14%0.80%0.59%
1 Year Performance5.61%14.26%13.79%20.55%

Bowhead Specialty Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BOW
Bowhead Specialty
4.0323 of 5 stars
$33.68
+10.1%
$33.43
-0.7%
-4.0%$1.11B$584.46M19.47193
HGTY
Hagerty
2.2164 of 5 stars
$12.15
+2.8%
$13.67
+12.4%
+15.1%$4.06B$1.46B60.771,891
FG
F&G Annuities & Life
3.2686 of 5 stars
$30.45
+2.8%
$30.00
-1.5%
-9.0%$3.93B$5.73B7.991,173
BWIN
Baldwin Insurance Group
3.0102 of 5 stars
$28.63
+4.5%
$30.00
+4.8%
-21.4%$3.91B$1.50BN/A5,020
ALHC
Alignment Healthcare
4.2478 of 5 stars
$18.43
-1.3%
$24.30
+31.9%
+14.5%$3.86B$3.95B204.781,849

Related Companies and Tools


This page (NYSE:BOW) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners